Prostatic Neoplasms, Castration-Resistant Active Not Recruiting Phase 1 Trials for Rosuvastatin (DB01098)

IndicationStatusPhase
DBCOND0001230 (Prostatic Neoplasms, Castration-Resistant)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02592317A Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Participants With Castration-Resistant Prostate CancerTreatment